08D Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mirum Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 68.72 EUR -2.44% Market Closed

Market Cap: €3.2B

	Mirum Pharmaceuticals Inc F:08D	US
	Akobo Minerals AB (publ) F:643	SE

Profitability Summary

Mirum Pharmaceuticals Inc's profitability score is 18/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

82% > 82%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-27%

Operating Margin is Increasing

-77% > -15%

Negative Net Margin

-139%

Negative 3Y Average Net Margin

-53%

Declining Net Margin

-113% > -139%

Negative Free Cash Flow Margin

-43%

Negative 3Y Average Free Cash Flow Margin

-14%

Free Cash Flow Margin is Increasing

-72% > -43%

Negative ROE

-703%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-26%

ROIC is Increasing

-44% > -19%

View All

Hide

Collapse

18 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.